Decreased self-esteem, depression
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Informed consent, presence of intellectual impairment, presence of depressive symptoms, presence of internet access and smartphone, willingness to participate in two anonymous online surveys, willingness to participate in the 4-week self-help smartphone app intervention, willingness to use the self-help smartphone app on their own responsibility, willingness to leave an anonymous email address.
Exclusion criteria
Exclusion criteria: Acute suicidality (as measured by the GDS-LD and GDS-CS Item 14), current or former presence of bipolar or psychotic illness, or alcohol dependence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Glasgow Depression Scale (GDS) is used as the primary outcome parameter to assess depressive symptoms (T0 and T1 after 4 weeks). The GDS is a self-report questionnaire for mild to moderate intelligence impairment (IM). For subjects who are unable to self-rate, we elicit depressive symptoms via the Glasgow Depression Scale - Carer Supplement (GDS-CS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome parameters are the Rosenberg Self-Esteem Scale (RSE) to measure self-esteem (T0 and T1) and to assess the degree of self-esteem in the last week (at T0 and T1 after 4 weeks), 8 items of the WHOQoL Questionnaire in easy language to assess quality of life (T0 and T1). Secondary parameters will also be assessed by a carer-supplement rating, if subjects are able to complete the self-rating. At T0, sociodemographic data and psychiatric history will additionally be collected. At T1 after 4 weeks, patient satisfaction will additionally be assessed by the Patient Satisfaction Questionnaire (ZUF-8). | — |
Countries
Germany
Contacts
Universitätsklinikum Hamburg-Eppendorf